News & Views
- MLCSU-supported finance team win award
- MLCSU director named HSJ100 wildcard for 2022
- Our experts at NHS ConfedExpo: Schedule announced
- MLCSU nominated for three NHS Health and Care Apprenticeship Awards
- We’re exhibiting at NHS ConfedExpo, 15-16 June
- Innovative NHS resource-booking system signs up 20th customer
- Blog: How can digital advances help a greener NHS?
- Blog: Why digital advances are so important to new hospitals
- 2021, our journey alongside ICS partners
- Blog: Treating people on waiting lists: who decides what is fair?
- Kicking off a study on menopause and the NHS workforce
- MLCSU Gender Pay Gap Report 2021
- CQRS Local will reduce admin time for commissioners and primary care providers
- Blog: Decision makers can make much better use of analysis
- PCNs critical in population health management
Improving medicines safety in care homes
Through structured medication reviews, we supported the proactive management of individual care home patients needs, saving over £149,000 in drug costs and on average 62 GP appointments per month across the Black Country and West Birmingham Sustainability and Transformation Partnership.
NHS England and NHS Improvement commissioned MLCSU to deliver its Medicines Optimisation in Care Homes (MOCH) pilot project across The Black Country and West Birmingham Sustainability and Transformation Partnership. This programme is focused on integrating pharmacists and pharmacy technicians into the wider primary care workforce and supporting patients in care homes.
Midlands and Lancashire Commissioning Support Unit pharmacists worked as part of a multidisciplinary team to provide leadership on person-centred medicines optimisation. Several services were provided including 30-minute, in-depth, structured medication reviews, pharmacy technician led medicines waste audits and system reviews to support medicines safety.
The programme is improving outcomes and access for patients, relieving the pressure on GPs and accident and emergency departments, ensuring best use of medicines, and driving better value. The structured medication reviews have supported the proactive management of individual patient need, improving their quality of life.
The pilot project generated actual drug cost efficiencies of over £149,000 (excluding cost improvement from potential hospital admissions avoidance), with a saving per patient reviewed of £100. The service freed up on average 62 GP appointments per month (this excludes setup time, and pause caused by the COVID-19 pandemic), plus time spent on processing 100 outpatient and 46 discharge letters.
The care home system review provided assurance across a range of areas and identified where improvements were required.
All of the care homes were found to require improvement in at least 35 per cent of the areas examined.
All were deficient in the areas of medicine policy and medical records
Where more than 70 per cent were deficient in the same area, this was classed as a priority theme and 55 per cent of priority theme areas required urgent improvement. These were self-administration, staff training, ordering and receipt of medicines, safe storage of medicines and medication alerts and adverse reactions.
Over £1,222 of avoidable waste was identified from waste medicine audits in 11 of the care homes.
The pharmacy technician provided training to improve repeat prescribing processes within care homes; supporting communication between care homes, GP practices and community pharmacy to embed the new way of working. Training also covered the 28-day medication cycle, expiry date guidance document and good practice on disposal of medicines.
100% of care home and GP practice staff, and patients responding to surveys said they’d recommend this service